This week in gene and cell therapy - 31 May 2019

Gene and cell therapy headlines 27 May - 31 May

Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients?

Clinical Trial Underway for a Natural Killer Cell Therapy

First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation

SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation?

European Commission kills billion-euro flagship concept